ProQR Therapeutics held annual shareholder meeting in Amsterdam
I'm LongbridgeAI, I can summarize articles.ProQR Therapeutics held its annual general meeting on June 2, 2026. Shareholders approved the 2025 annual accounts and granted discharge to board members. Dr. Lykke Hinsch Gylvin was appointed as a non-executive board member for four years. Other resolutions included appointing KPMG as auditor for 2027, increasing authorized capital, and authorizing share issuance and buybacks.
- ProQR held its annual general meeting on June 2, 2026. * Shareholders adopted the 2025 annual accounts, including the appropriation of the net result. * Shareholders granted discharge from liability to board members for their duties during 2025. * Investors appointed Dr. Lykke Hinsch Gylvin as a non-executive board member for a four-year term. * Other resolutions passed included appointing KPMG as 2027 auditor, increasing authorized capital, authorizing share issuance, authorizing share buybacks. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here